Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B. (Q45354091)

13 December 2017

Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B. (English)

1 reference

13 December 2017

1 reference

1 reference

Benedetta Donati

9

0 references

Roberta D'Ambrosio

Roberta D'Ambrosio

6

0 references

Pietro Lampertico

Pietro Lampertico

3

0 references

Benedetta Maria Motta

Benedetta Maria Motta

5

0 references

Luca Valenti

Luca Valenti

2

0 references

author name string

Mauro Viganò

1

1 reference

13 December 2017

Floriana Facchetti

4

1 reference

13 December 2017

Solange Romagnoli

7

1 reference

13 December 2017

Paola Dongiovanni

8

1 reference

13 December 2017

Silvia Fargion

10

1 reference

13 December 2017

Massimo Colombo

11

1 reference

13 December 2017

language of work or name

English

0 references

publication date

6 August 2013

1 reference

13 December 2017

1 reference

13 December 2017

58

1 reference

13 December 2017

4

1 reference

13 December 2017

1245-1252

1 reference

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

13 December 2017

1 reference

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

21 January 2018

1 reference

Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese.

21 January 2018

1 reference

Viral and host causes of fatty liver in chronic hepatitis B

21 January 2018

1 reference

Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis

21 January 2018

1 reference

Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis

21 January 2018

1 reference

Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.

21 January 2018

1 reference

Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C.

21 January 2018

1 reference

Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B.

21 January 2018

1 reference

Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors

21 January 2018

1 reference

Clinical expression of insulin resistance in hepatitis C and B virus-related chronic hepatitis: differences and similarities.

21 January 2018

1 reference

Predictors of hepatic steatosis in HBeAg-negative chronic hepatitis B patients and their diagnostic values in hepatic fibrosis

21 January 2018

1 reference

Insulin resistance in chronic hepatitis B virus infection

21 January 2018

1 reference

Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection

21 January 2018

1 reference

Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C

21 January 2018

1 reference

Hepatitis B virus infection and fatty liver in the general population

21 January 2018

1 reference

A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based Integrated Screening study No. 10).

21 January 2018

1 reference

Insulin resistance is not associated with histologic severity in nondiabetic, noncirrhotic patients with chronic hepatitis B virus infection

21 January 2018

1 reference

Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese.

21 January 2018

1 reference

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

21 January 2018

1 reference

Polymorphisms in the adiponutrin gene are associated with increased insulin secretion and obesity

21 January 2018

1 reference

Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene

21 January 2018

1 reference

A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans

21 January 2018

1 reference

Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity.

21 January 2018

1 reference

The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent

21 January 2018

1 reference

PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease

21 January 2018

1 reference

A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis

21 January 2018

1 reference

Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase

21 January 2018

1 reference

Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease

21 January 2018

1 reference

Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin.

21 January 2018

1 reference

I148M PNPLA3 variant and progressive liver disease: A new paradigm in hepatology

21 January 2018

1 reference

Dual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validation.

21 January 2018

1 reference

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

PNPLA3 gene-by-visceral adipose tissue volume interaction and the pathogenesis of fatty liver disease: the NHLBI family heart study

21 January 2018

1 reference

The association of PNPLA3 variants with liver enzymes in childhood obesity is driven by the interaction with abdominal fat.

21 January 2018

1 reference

Variant in PNPLA3 is associated with alcoholic liver disease

21 January 2018

1 reference

Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis

21 January 2018

1 reference

Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B.

21 January 2018

1 reference

The interaction of metabolic factors with HCV infection: does it matter?

21 January 2018

1 reference

Genetic variants in PNPLA3 and risk of non-alcoholic fatty liver disease in a Han Chinese population

21 January 2018

1 reference

Impact of liver steatosis on response to pegylated interferon therapy in patients with chronic hepatitis B

21 January 2018

1 reference

PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosis.

21 January 2018

1 reference

The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis

21 January 2018

1 reference

PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.

21 January 2018

1 reference

Distinct, alcohol-modulated effects of PNPLA3 genotype on progression of chronic hepatitis C

21 January 2018

1 reference

Patatin-like phospholipase domain-containing protein 3 genotype and hepatocellular carcinoma in chronic hepatitis C

21 January 2018

1 reference

Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians

21 January 2018

1 reference

How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?

21 January 2018

1 reference

7 January 2021

Histopathological study of chronic hepatitis B and C: a comparison of two scoring systems

1 reference

7 January 2021

Impact of non-alcoholic fatty liver disease on chronic hepatitis B

1 reference

7 January 2021

Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection?

1 reference

7 January 2021

Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B

1 reference

7 January 2021

Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro

1 reference

7 January 2021

Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C

1 reference

7 January 2021

Interaction between IL28B and PNPLA3 genotypes in the pathogenesis of steatosis in chronic hepatitis C non genotype-3 patients

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.26445

1 reference

13 December 2017

1 reference